Inventor · disambiguated record
Timothy J. Church
Also filed as: CHURCH TIMOTHY J · CHURCH TIMOTHY JAMES
35 granted patents·11 pending applications·553 citations·filing 1999–2023
98Inventor score
Files withTHERAVANCE INC14DICE ALPHA INC8AXT SABINE4THERAVANCE BIOPHARMA R&D IP LLC4ADVANCED MEDICINE INC3
Top patents by PatentIndex Score
46 records- 0198US7700777B2Crystalline forms of a biphenyl compoundTHERAVANCE INC·Filed 2007·Granted Apr 20, 2010·42 cites·8 claims
- 0298US6670376B1Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2002·Granted Dec 30, 2003·129 cites·40 claims
- 0397US11390603B2Crystalline forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Jul 19, 2022·5 cites·6 claims
- 0497US7622508B28-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Nov 24, 2009·39 cites·19 claims
- 0596US8242137B2Crystalline forms of a biphenyl compoundAXT SABINE·Filed 2009·Granted Aug 14, 2012·24 cites·14 claims
- 0695US8377965B2Crystalline forms of a biphenyl compoundTHERAVANCE INC·Filed 2010·Granted Feb 19, 2013·20 cites·14 claims
- 0795US7888386B23-(phenoxyphenylmethyl)pyrrolidine compoundsTHERAVANCE INC·Filed 2009·Granted Feb 15, 2011·30 cites·54 claims
- 0894US9656993B2Crystalline forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2015·Granted May 23, 2017·10 cites·7 claims
- 0994US8263618B28-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonistsLONG DANIEL D·Filed 2009·Granted Sep 11, 2012·18 cites·15 claims
- 1093US8716313B2Crystalline forms of a biphenyl compoundAXT SABINE·Filed 2013·Granted May 6, 2014·14 cites·16 claims
- 1192US10577347B2Crystalline forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Mar 3, 2020·6 cites·7 claims
- 1292US7902220B28-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonistsTHERAVANCE INC·Filed 2008·Granted Mar 8, 2011·14 cites·14 claims
- 1392US6479498B1Sodium channel drugs and usesTHERAVANCE INC·Filed 2001·Granted Nov 12, 2002·36 cites·12 claims
- 1491US9249099B2Crystalline forms of a biphenyl compoundAXT SABINE·Filed 2014·Granted Feb 2, 2016·8 cites·19 claims
- 1591US8921395B2Crystalline forms of a biphenyl compoundAXT SABINE·Filed 2014·Granted Dec 30, 2014·8 cites·17 claims
- 1689US11274094B2Substituted benzenecarboxamides as IL-17A modulatorsDICE ALPHA INC·Filed 2020·Granted Mar 15, 2022·2 cites·60 claims
- 1789US6355637B1Local anesthetic compoundsADVANCED MEDICINE INC·Filed 2000·Granted Mar 12, 2002·35 cites·25 claims
- 1888US8242164B23-(phenoxyphenylmethyl)pyrrolidine compoundsSTANGELAND ERIC L·Filed 2011·Granted Aug 14, 2012·9 cites·9 claims
- 1987US6562854B2Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disordersAXYS PHARM INC·Filed 2001·Granted May 13, 2003·19 cites·16 claims
- 2086US8481563B28-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonistsSAITO DAISUKE ROLAND·Filed 2011·Granted Jul 9, 2013·7 cites·19 claims
- 2185US7582765B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2007·Granted Sep 1, 2009·2 cites·16 claims
- 2284US8518966B2Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonistsLONG DANIEL D·Filed 2011·Granted Aug 27, 2013·6 cites·19 claims
- 2384US2022388981A1Crystalline forms of a biphenyl compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
- 2478US11447468B2IL-17 ligands and uses thereofDICE ALPHA INC·Filed 2020·Granted Sep 20, 2022·1 cites·17 claims
- 2575US12421212B2Substituted benzenecarboxamides as IL-17A modulatorsDICE ALPHA INC·Filed 2022·Granted Sep 23, 2025·0 cites·10 claims
- 2675US6420354B1Sodium channel drugs and usesADVANCED MEDICINE INC·Filed 1999·Granted Jul 16, 2002·45 cites·13 claims
- 2775US2023145481A1Substituted benzenecarboxamides as il-17a modulatorsDICE ALPHA INC·Filed 2022·Application pending·0 cites
- 2875US2023141212A1Substituted benzenecarboxamides as il-17a modulatorsDICE ALPHA INC·Filed 2022·Application pending·0 cites
- 2974US7553971B2Aryl aniline β2 adrenergic receptor agonistsTHERAVANCE INC·Filed 2006·Granted Jun 30, 2009·1 cites·14 claims
- 3068US9163027B2Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survivalSTATEGICS INC·Filed 2013·Granted Oct 20, 2015·2 cites·43 claims
- 3166US12234225B2IL-17 ligands and uses thereofDICE ALPHA INC·Filed 2022·Granted Feb 25, 2025·0 cites·20 claims
- 3263US9657024B2Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survivalSTATEGICS INC·Filed 2013·Granted May 23, 2017·1 cites·36 claims
- 3363US2007112027A1Crystalline forms of a biphenyl compoundTHERAVANCE INC·Filed 2006·Application pending·0 cites
- 3461US2025313535A1Alpha 4 beta 7 integrin modulators and uses thereofDICE MOLECULES SV INC·Filed 2023·Application pending·0 cites
- 3560US2025177383A1Di-cyclopropyl based il-17a modulators and uses thereofDICE ALPHA INC·Filed 2023·Application pending·0 cites
- 3658US2024376056A1Phenyl acetamide based il-17a modulators and uses thereofDICE ALPHA INC·Filed 2022·Application pending·0 cites
- 3758US2003229058A1Aryl aniline beta2 adrenergic receptor agonistsFiled 2003·Application pending·0 cites
- 3857US8933249B23-(phenoxyphenylmethyl)pyrrolidine compoundsSTANGELAND ERIC L·Filed 2012·Granted Jan 13, 2015·0 cites·28 claims
- 3957US6576791B1Local anesthetic compounds and usesTHERAVANCE INC·Filed 1999·Granted Jun 10, 2003·10 cites·11 claims
- 4052US6337423B1Local anesthetic compounds and usesADVANCED MEDICINE INC·Filed 1999·Granted Jan 8, 2002·7 cites·30 claims
- 4150US6495681B1Local anesthetic compounds and usesTHERAVANCE INC·Filed 2000·Granted Dec 17, 2002·0 cites·14 claims
- 4247US6436919B1Local anesthetic compoundsTHERAVANCE INC·Filed 2000·Granted Aug 20, 2002·0 cites·13 claims
- 4346US2003212120A1Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disordersAXYS PHARM INC·Filed 2003·Application pending·0 cites
- 4445US6462034B1Local anesthetic compounds and usesTHERAVANCE INC·Filed 1999·Granted Oct 8, 2002·3 cites·18 claims
- 4535US2010267743A13-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compoundsSTANGELAND ERIC L·Filed 2010·Application pending·0 cites
- 4632US2017153257A1Methods of estimating logd of tagged combinatorial library compoundsDICE MOLECULES SV LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy J. Church files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →